Ferrostatin-1 (Fer-1) for Ferroptosis Assays
2026-09-08
Use Ferrostatin-1 (Fer-1) as a nanomolar rescue control to distinguish ferroptosis from nonspecific oxidative cytotoxicity. This workflow connects mechanistic cell assays with sonodynamic therapy, cancer biology research, and neurodegenerative disease models while emphasizing controls that improve reproducibility.
APEX2 Supports TERT Expression in Human Stem Cells
2026-09-08
A bioRxiv study identifies APEX2, but not its paralog APEX1, as a DNA repair factor required for efficient TERT expression in human embryonic stem cells and melanoma cells. Its RNA-seq and chromatin-immunoprecipitation data connect TERT regulation with repair-prone repetitive DNA, providing a mechanistic framework for studying telomerase control in stem cell biology and cancer.
Protease Inhibitor Cocktail: K1010 Guide
2026-09-07
This scenario-based guide explains how Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO), SKU K1010, helps preserve protein integrity in viability, cytotoxicity, phosphorylation, Western blot, and immunoprecipitation workflows. It covers compatibility, dilution, interpretation, limitations, and practical vendor-selection criteria.
Gamithromycin: Lung-Targeted Research Workflows
2026-09-05
Gamithromycin supports respiratory infection research with a workflow that connects matrix-aware susceptibility testing to lung and phagocytic-cell exposure. This guide translates pharmacokinetic findings into practical assay design, PK/PD interpretation, and troubleshooting for veterinary pathogen studies.
EVMPs for Extrahepatic mRNA Delivery
2026-09-05
The reference study presents a bottom-up, self-assembling enveloped virus-mimicking particle (EVMP) designed to overcome the liver bias of many mRNA delivery systems. By combining an engineered virus-mimicking peptide with tunable phospholipid envelopes, the authors achieved targeted delivery to lung and spleen tissues and demonstrated therapeutic activity with IL-12 mRNA in a metastatic lung tumor model.
Temafloxacin Pharmacokinetics: Key Findings
2026-09-04
Dudley’s 1991 review integrates absorption, distribution, elimination, renal function, and pharmacodynamic considerations for temafloxacin, showing high oral bioavailability, an approximately 8-hour half-life, and substantial tissue distribution. These findings support simplified dosing while illustrating how pharmacokinetic evidence can guide interval adjustment and translational antimicrobial research.
One-step TUNEL FITC: From Signal to Mechanism
2026-09-04
The One-step TUNEL FITC Apoptosis Detection Kit connects DNA fragmentation with mechanistic toxicology, offering a practical framework for interpreting apoptosis signals in environmental reproductive research. Learn how to pair FITC-labeled dUTP incorporation with tissue localization, flow cytometry, and omics-derived hypotheses.
Exendin-4 Workflows for Beta Cell Research
2026-09-03
Build reproducible Exendin-4 and Exenatide experiments around cAMP, insulin secretion, and proinsulin transcription rather than relying on a single endpoint. This guide connects beta-cell assays with metabolic models, yeast-based production research, and practical troubleshooting for type 2 diabetes research.
Niclosamide: From STAT3 Biology to Translational Strategy
2026-09-03
Niclosamide offers translational researchers a practical bridge between STAT3 pathway interrogation, phenotype-driven cancer research, and disciplined cross-domain evaluation. This thought-leadership guide connects mechanism, assay design, formulation, in vivo evidence, and ecological context while distinguishing established findings from forward-looking workflow recommendations.
7-Ethyl-10-hydroxycamptothecin: Assay Logic
2026-09-02
7-Ethyl-10-hydroxycamptothecin, also known as SN-38, is more than a topoisomerase I inhibitor. This article presents a mechanism-resolved assay framework that separates DNA replication stress, cell-cycle effects, apoptosis, and FUBP1/FUSE transcriptional disruption in advanced colon cancer research.
X-Gal: From Molecular Cloning to Translational Biology
2026-09-02
X-Gal is more than a blue-white colony screening reagent: it is a mechanistically transparent way to connect construct integrity with reporter biology. This article examines how 5-bromo-4-chloro-indolyl-β-D-galactopyranoside can support disciplined translational workflows, while using recent iRhom2 olfaction research to define both the opportunity and the boundaries of cross-domain application.
Dual Recombinase Tracing Rules Out Mouse Neo-Oogenesis
2026-09-01
Xie, Zhou, and Zheng used orthogonal Cre-loxP and Dre-rox lineage tracing to test whether non-germ ovarian cells generate new oocytes after birth. Across physiological aging and busulfan-induced ovarian injury, the study detected no labeled growing oocytes or metaphase II eggs, strengthening the conclusion that postnatal neo-oogenesis does not occur in vivo in mice.
Cefepime (BMY-28142) in Resistance-Aware Assays
2026-08-31
Cefepime (BMY-28142) can do more than serve as a beta-lactam challenge in bacterial infection models. This article presents a resistance-aware assay framework that connects cefepime phenotype, carbapenemase gene localization, plasmid transfer, and CNS infection research without confusing in vitro findings with clinical conclusions.
Central Control of Opioid Mechanical Hypersensitivity
2026-08-31
Yin et al. identify a brain-to-spinal opioid circuit linking MOR-expressing neurons in the lateral parabrachial nucleus, dynorphin neurons in the paraventricular hypothalamus, and KOR-expressing GABAergic neurons in the spinal dorsal horn. Their mouse experiments show that disrupting this pathway can alleviate morphine-induced mechanical hypersensitivity and analgesic tolerance, clarifying a central mechanism relevant to opioid receptor pharmacology and chronic pain research.
Separating Growth Inhibition from Cancer Cell Death
2026-08-30
Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a framework for distinguishing proliferative arrest from cell killing and for interpreting their different magnitudes and time courses in cancer research.
461 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page